Related Experiment Video
Updated: Jul 4, 2026

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Progression from acute kidney injury to chronic kidney disease: a pediatric perspective
Stuart L Goldstein1, Prasad Devarajan
1Department of Pediatrics, Renal Section, Baylor College of Medicine, Houston, TX, USA.
Insights
Rising acute kidney injury (AKI) and chronic kidney disease (CKD) in children lack early diagnostic tools. New biomarkers show promise for timely intervention, improving pediatric kidney disease outcomes.
Area of Science:
- Pediatric Nephrology
- Biomarker Discovery
- Kidney Disease Research
Background:
- Pediatric acute kidney injury (AKI) and chronic kidney disease (CKD) incidence is increasing with evolving causes.
- The transition from AKI to CKD in children is poorly understood, hindering early intervention.
- Current diagnostic limitations, including a lack of uniform AKI definitions and predictive biomarkers, impede timely treatment.
Purpose of the Study:
- To review the current understanding of AKI to CKD transition in children.
- To highlight advancements in pediatric AKI classification and biomarker identification.
- To discuss the potential of novel biomarkers for early AKI and CKD detection in pediatric populations.
Main Methods:
- Review of recent scientific literature on pediatric AKI and CKD.
- Analysis of emerging multidimensional AKI classification systems for children.
- Identification and discussion of novel biomarker candidates (e.g., NGAL, L-FABP, KIM-1).
Main Results:
- A validated multidimensional AKI classification system for children has been established.
- Novel biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty acid-binding protein (L-FABP), and kidney injury molecule-1 (KIM-1) show potential for early detection.
- Ongoing studies are validating these biomarkers in large pediatric cohorts.
Conclusions:
- Early detection and intervention are crucial for improving pediatric kidney disease prognosis.
- New classification systems and biomarkers offer hope for earlier diagnosis of AKI and CKD in children.
- Further validation of biomarkers is essential for clinical application in pediatric nephrology.
Abstract:
Although emerging evidence indicates that the incidence of both acute kidney injury (AKI) and chronic kidney disease (CKD) in children is rising and the etiologies are dramatically changing, relatively little is currently known regarding the potential for transition from AKI to CKD. In both situations, early intervention can significantly improve the dismal prognosis. However, the lack of a uniform AKI definition and the paucity of early, predictive biomarkers have impaired our ability diagnose AKI early to institute potentially effective therapies in a timely manner. Fortunately, recent data has validated a multidimensional AKI classification system for children. In addition, the application of innovative technologies has identified candidates that are emerging as early biomarkers of both AKI and CKD. These include neutrophil gelatinase-associated lipocalin, liver-type fatty acid-binding protein, and kidney injury molecule-1. Studies to validate the sensitivity and specificity of these biomarkers in clinical samples from large cohorts and from multiple clinical situations are currently in progress, facilitated by the development of commercial tools for the reproducible measurement of these biomarkers across different laboratories.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

